NEWARK, CA / ACCESS Newswire / April 16, 2025 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company"), a ...

The grant to Dr. Shah provides for the issuance of 191,624 stock options. Additionally, the grants to the two employees provide for the issuance of an aggregate of 21,000 stock options. Each grant ...

Royden Brousseau has eaten a lot of sandwiches over the last year. After an interview with a Free Press reporter on a recent ...

(Reuters) - Kinder Morgan narrowly missed Wall Street expectations for first-quarter profit on Wednesday after the U.S.